N6-Benzoyl-7’-OH-N-trityl morpholino adenine
Modify Date: 2025-09-18 13:39:12
N6-Benzoyl-7’-OH-N-trityl morpholino adenine structure
|
Common Name | N6-Benzoyl-7’-OH-N-trityl morpholino adenine | ||
|---|---|---|---|---|
| CAS Number | 956139-16-5 | Molecular Weight | 596.68 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C36H32N6O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of N6-Benzoyl-7’-OH-N-trityl morpholino adenineN6-Benzoyl-7’-OH-N-trityl morpholino adenine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | N-{9-[(2R,6S)-6-(Hydroxymethyl)-4-trityl-2-morpholinyl]-9H-purin-6-yl}benzamide |
|---|---|
| Synonym | More Synonyms |
| Description | N6-Benzoyl-7’-OH-N-trityl morpholino adenine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Molecular Formula | C36H32N6O3 |
| Molecular Weight | 596.68 |
| Exact Mass | 596.253601 |
| LogP | 6.14 |
| Index of Refraction | 1.686 |
| MFCD22666304 |
| N-{9-[(2R,6S)-6-(Hydroxymethyl)-4-trityl-2-morpholinyl]-9H-purin-6-yl}benzamide |
| Benzamide, N-[9-[(2R,6S)-6-(hydroxymethyl)-4-(triphenylmethyl)-2-morpholinyl]-9H-purin-6-yl]- |